0001415889-24-019331.txt : 20240708 0001415889-24-019331.hdr.sgml : 20240708 20240708160506 ACCESSION NUMBER: 0001415889-24-019331 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240703 FILED AS OF DATE: 20240708 DATE AS OF CHANGE: 20240708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Durso-Bumpus Debra CENTRAL INDEX KEY: 0001802970 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 241104699 MAIL ADDRESS: STREET 1: C/O BLUEPRINT MEDICINES CORORATION STREET 2: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4-07082024_040702.xml X0508 4 2024-07-03 0001597264 Blueprint Medicines Corp BPMC 0001802970 Durso-Bumpus Debra C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 false true false false CHIEF PEOPLE OFFICER 1 Common Stock 2024-07-03 4 M 0 8817 54.13 A 52580 D Common Stock 2024-07-03 4 S 0 8817 111.29 D 43763 D Common Stock 2024-07-05 4 M 0 3850 54.13 A 47613 D Common Stock 2024-07-05 4 S 0 3850 111.20 D 43763 D Stock Option (Right to Buy) 54.13 2024-07-03 4 M 0 8817 0 D 2030-03-01 Common Stock 8817 3850 D Stock Option (Right to Buy) 54.13 2024-07-05 4 M 0 3850 0 D 2030-03-01 Common Stock 3850 0 D Effected pursuant to a trading plan adopted on March 13, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $111.00 to $111.97 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (3) in this form 4. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $111.00 to $111.34 per share. This option was granted on March 1, 2020 and is fully vested as of the transaction date. /s/ Melissa Masse 2024-07-08